Rapha Capital BioVentures Fund I Launches DELIVER Therapeutics Inc. with $3 Million Convertible Note Financing
Retrieved on:
Tuesday, December 14, 2021
Therapy, Executive, RNA, Drug discovery, OTC, Series, Blackstreet Capital Management, Company, Doctor of Philosophy, IPO, Baylor College of Medicine, Genomics, Convertible, Center, Medicine, Sławin, RCM, Cancer, NASDAQ, LLC, Immunotherapy, Associate, CEO, Baylor University, Disease, Spencer, CFO, Enzyme, CSO, Investment, Multimedia, COO, MD, Founder, Peptide, Ageing, Spiv, Technology, Lead, Arrest, Financial services, Management, DRS
Rapha Capital is an investment management firm focused on making strategic investments in early stage, non-public biotechnology companies, through special purpose, joint venture entities which it manages.
Key Points:
- Rapha Capital is an investment management firm focused on making strategic investments in early stage, non-public biotechnology companies, through special purpose, joint venture entities which it manages.
- About Rapha Capital Management, LLC and Rapha Capital BioVentures Fund I, LP Rapha Capital Management, LLC is an investment management firm located in Miami, Florida, focusing on strategic investments in early stage, non-public biotechnology companies.
- Rapha Capital Management offers alternative asset management services to the RCBV Fund, which is the vehicle for all current and future investments managed by Rapha Capital Management.
- For more information about DELIVER Therapeutics, Inc., email [email protected] or visit https://www.delivertherapeutics.com
For more information about Rapha Capital Management, email [email protected] or visit https://www.raphacap.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/rapha-capital-bioventures-fund-...